Co-Diagnostics Reports Second Quarter 2026 Financial Results
Co-Diagnostics Reports Second Quarter 2026 Financial Results Co-Diagnostics Reports Second Quarter 2026 Financial Results PR Newswire SALT LAKE CITY, Aug. 13, 2026 Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing ExpansionStrengthening Integrated Co-Dx...
PR Newswire
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test PR Newswire SALT LAKE CITY, Aug. 6, 2026 Submission includes a concurrent CLIA Waiver by Application...
PR Newswire
Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast
Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY, July 30, 2026 SALT LAKE CITY, July 30, 2026 /PRNewswire/ -- Co-Diagnostics, Inc.(Nasdaq: CODX) ("Co-Dx" or "the...
PR Newswire
Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies
Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies PR Newswire SALT LAKE CITY, July 28, 2026 Company also completes proof of concept for the first blood-borne test for Ebola on Co-Dx...
PR Newswire
Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform
Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform PR Newswire SALT LAKE CITY, July 22, 2026 PCR Pro Instruments and MTB Test Kits...
PR Newswire
EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin
Co-Diagnostics' India joint venture CoSara has started clinical studies for its rapid TB PCR test, advancing deployment of its point-of-care platform.read more...
Benzinga
Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer
Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer PR Newswire SALT LAKE CITY, July 16, 2026 SALT LAKE CITY, July 16, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX)("Co-Dx" or "the Company...
PR Newswire
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand PR Newswire SALT LAKE CITY, July 8, 2026 Invited by the Stop TB Partnership and the Global Fund...
PR Newswire
Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test
Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test PR Newswire SALT LAKE...
PR Newswire
EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform
Co-Diagnostics completed clinical and analytical studies for its PCR Flu A/B & RSV test and plans FDA 510(k) and CLIA waiver submissions.read more...
Benzinga